International tensions over Uruguay’s decision to regulate the cannabis market reached new levels when Raymond Yans, president of the International Narcotics Control Board (INCB), accused Uruguay of negligence with regard to public health concerns, deliberately blocking dialogue attempts and having a "pirate attitude" towards the UN conventions. President Mujica reacted angrily, declaring that someone should "tell that guy to stop lying," while Milton Romani, ambassador to the Organisation of American States (OAS), said that Yans "should consider resigning because this is not how you treat sovereign states."
Uruguay’s president has accused the head of the UN’s International Narcotics Control Board (INCB), Raymond Yans, of lying and double standards, after the official claimed the country did not consult the anti-drug body before legalizing marijuana.
Uruguay's President Mujica shot back at the president of the International Narcotics Control Board, a U.N. agency, for saying that his administration refused to meet with the agency’s officials before legalizing marijuana. Mujica batted down the criticism, insisting that his administration is open to discussing the law and accusing the INCB President Raymond Yans of applying a double standard by criticizing Uruguay, even as U.S. states pass laws to legalize recreational marijuana consumption. "Tell this old guy not to lie," Mujica said.
The US drug policy is changing, pitting states against federal law. This essay explores this inner friction of contradictory drug legislation, and what it may mean for the international drug control regime, itself a result of US drug policy. (4,400 words)
Despite its unprecedented nature within the history of the international drug control regime, and regardless of warnings to the contrary, the Plurinational State of Bolivia’s withdrawal from the 1961 Single Convention on Narcotic Drugs on 1 January 2012 did not result in a collapse of the United Nations (UN) based control system. That said, there is a strong case that, although marking the centenary of the regime, 2012 will be seen as the beginning of the end of the treaty system in its present form and the re-structuring of a policy world apparently so cherished by many members of the International Narcotics Control Board.
Reflections upon this year’s CND are mixed. On the one hand, some states went further than ever before in openly challenging the current regime on the grounds that, after a century, it needs modernising. That the government of Uruguay is currently considering a domestic policy on cannabis that would put it in breach of the Single Convention shows that, in one instance at least, we have moved beyond rhetoric and posturing.
Ann Fordham of the International Drug Policy Consortium (IDPC) delivered the NGO Statement to CND Plenary under Item 8: Preparations for the high-level review of the implementation by Member States of the Political Declaration and Plan of Action on International Cooperation towards an integrated and balanced strategy to counter the world drug problem.
The United States must not turn a blind eye to the recreational use of cannabis in states that liberalize drug laws, the International Narcotics Control Board (INCB) said, urging the country to live up to its treaty commitments. Raymond Yans, president of the INCB, said assurances from the U.S. government in December that growing, selling or possessing the drug remained illegal under federal law were "good, but insufficient".
Daniel Wolfe, director of the International Harm Reduction Development Program, director of Open Society Foundations Global Drug Policy Program
04 March 2013
In what has become a chilling annual exercise, the UN's drug watchdog the International Narcotics Control Board released its annual report today. The INCB describes itself as a "quasi-judicial" group of experts charged with monitoring compliance with international drug control treaties, but the report's drug war bias and egregious omissions makes us wonder who is judging the judges.
A major international row with wide-ranging implications for global drugs policy has erupted over the right of Bolivia's indigenous Indian tribes to chew coca leaves, the principal ingredient in cocaine.